55 results on '"Rockoff, Jonathan D."'
Search Results
2. Coronavirus Drugs, Vaccine Are Many Months Away, Health Experts Say.
3. Pfizer Nears Deal to Combine off-Patent Drug Business With Mylan.
4. Pfizer CEO Read to Step Aside at Year’s End.
5. Pfizer CEO Read to Step Aside at Year’s End.
6. Pfizer Counts on Pipeline to Bring Growth.
7. Pfizer to Raise R&D Spending as Pipeline Focus Sharpens.
8. Pfizer to Roll Back Price Increases After Trump Criticism.
9. Pfizer to Roll Back Price Increases After Trump Criticism.
10. Pfizer to Roll Back Price Increases After Trump Criticism.
11. Trump, in Tweet, Criticizes Pfizer Price Increases.
12. Trump, in Tweet, Criticizes Pfizer Price Increases.
13. Pfizer Raises Prices for Dozens of Drugs.
14. Pfizer to Pay $24 Million to Settle Probe Into Copay Assistance Charities.
15. EpiPen Emergency Allergy Shot in Short Supply, FDA Says.
16. Pfizer Revenue Growth Stalls as Company Mulls OTC Unit’s Future.
17. P&G to Acquire Merck KGaA’s Consumer-Health Unit.
18. New Drug Combinations Improve Survival in Lung Cancer.
19. Johnson & Johnson Results Driven by Pharmaceutical Sales Growth.
20. Pfizer Ends Hunt for Drugs to Treat Alzheimer’s and Parkinson’s.
21. Why Cash Returning From Overseas Isn’t Likely to Create Jobs—and Might Even Reduce Them.
22. Pfizer Expects Wave of New Launches.
23. Pfizer Considers a Sale or Spinoff of Its Consumer Healthcare Business.
24. Baxter Says Saline Shipments Disrupted in Hurricane-Wracked Puerto Rico.
25. Baxter Says Saline Shipments Disrupted in Hurricane-Wracked Puerto Rico.
26. Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies.
27. Tandem Drug-Price Increases Take Toll on Some Patients.
28. Pfizer Cuts Outlook, Ends Development of Cholesterol Drug.
29. Pfizer to Sell New York City Headquarters By End of Next Year.
30. J&J Warns Insulin Pump Vulnerable to Cyber Hacking.
31. Pfizer Throws Out Plan to Split Into Two Companies.
32. Pfizer Throws Out Plan to Split Into Two Companies.
33. Pfizer to Buy Medivation for $14 Billion.
34. Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions.
35. Pfizer to Buy Medivation for $14 Billion.
36. Pfizer Nears Agreement to Buy Medivation.
37. Pfizer Nears Agreement to Buy Medivation.
38. Allergan Revenue Increases, Though Loss Widens.
39. Pfizer’s Results Beat Expectations.
40. Biogen Draws Takeover Interest From Rival Drugmakers.
41. Pfizer to Buy Anacor for $4.5 Billion.
42. Pfizer Reports Rock-Solid Quarter, Sees Stronger Year Ahead.
43. Pfizer, Allergan to Hunt for Deals of Their Own.
44. New Tax Rules on Inversion Deals Are Met With Protest.
45. Pfizer, Allergan to Hunt for Deals of Their Own.
46. Pfizer to Walk Away From Allergan Deal.
47. How Pfizer Set the Cost of Its New Drug at $9,850 a Month.
48. Pfizer, Allergan Agree on Historic Merger Deal.
49. Pfizer Heads for Fight With U.S. on Tax-Saving Allergan Deal.
50. Pfizer and Allergan Begin Merger Talks.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.